Loading organizations...
Loading organizations...
Biotechnology company developing gut health solutions with binding proteins
Bactolife has raised $73.0M across 3 funding rounds.
Bactolife has raised $73.0M in total across 3 funding rounds.
Bactolife has raised $73.0M in total across 3 funding rounds.
Bactolife's investors include Donna Parr, Sara Sande, Sophia Heyde, PhD, ATHOS, Julian Zachmann, Aleks Engel, Bill & Melinda Gates Foundation.
Bactolife has raised $73.0M across 3 funding rounds. Most recently, it raised $35.1M Series B in January 2026.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 6, 2026 | $35.1M Series B | Donna Parr, Sara Sande | Sophia Heyde, PhD, ATHOS |
| Aug 8, 2023 | $32.9M Series A | Julian Zachmann | Aleks Engel, Bill & Melinda Gates Foundation |
| Aug 30, 2022 | $5.0M Other Equity | Bill & Melinda Gates Foundation |